Research during COVID-19
Simon Collins, HIV i-Base
As if you didn’t already have enought to read…. The following four papers highlighting different issues related to research during COVID-19.
COVID-19 clinical trials: a teachable moment for improving our research infrastructure and relevance
A paper looking at issues related to trials design for compounds to treat COVID-19
Kimmel SE et al. Annals of Internal Medicine. DOI: 10.7326/M20-2959 (16 Jun 2020).
Proposing minimum requirements for announcing clinical trial results during the COVID-19 pandemic
This paper proposes minimal information that should be routinely included when researchers announce study results by press releases. This undemines the value of their research and restricts information needed to inform both standard of care and other ongoing research.
Siedner MJ et al. Clinical Infectious Diseases, ciaa945, DOI: 10.1093/cid/ciaa945. (8 July 2020).
Paying participants in COVID-19 trials
A paper on ethical issues related to paying participants in COVID-19 studies.
Largent EA et al. Journal of Infectious Diseases, Volume 222, Issue 3, 1 August 2020, Pages 356–361, DOI:10.1093/infdis/jiaa284.(29 May 2020).
Overcoming challenges in COVID-19 translational research
A paper on researcher collaborations on establishing a biobank and practical issues for optimising use of future samples.
Li JZ et al. Journal of Infectious Diseases, jiaa397, DOI: 10.1093/infdis/jiaa397. (7 July 2020).